0001375151-22-000002.txt : 20220121 0001375151-22-000002.hdr.sgml : 20220121 20220121212347 ACCESSION NUMBER: 0001375151-22-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220119 FILED AS OF DATE: 20220121 DATE AS OF CHANGE: 20220121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAST ERLE T CENTRAL INDEX KEY: 0001051411 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 22547301 MAIL ADDRESS: STREET 1: C/O SPIROS DEVELOPMENT CORP II INC STREET 2: 7475 LUSK BLVD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 500 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 500 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_164281821261987.xml FORM 4 X0306 4 2022-01-19 0 0001375151 ZOGENIX, INC. ZGNX 0001051411 MAST ERLE T C/O ZOGENIX, INC. 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 1 0 0 0 Stock Option (Right to Buy) 2022-01-19 4 M 0 6250 15.04 A 9277 D Stock Option (Right to Buy) 2022-01-19 4 M 0 4375 14.88 A 13652 D Stock Option (Right to Buy) 2022-01-19 4 M 0 4375 12 A 18027 D Stock Option (Right to Buy) 2022-01-19 4 S 0 15000 26.0864 D 3027 D Stock Option (Right to Buy) 15.04 2022-01-19 4 M 0 6250 0 D 2022-04-27 Common Stock 6250.0 0 D Stock Option (Right to Buy) 14.88 2022-01-19 4 M 0 4375 0 D 2022-06-06 Common Stock 4375.0 0 D Stock Option (Right to Buy) 12.0 2022-01-19 4 M 0 4375 0 D 2023-06-18 Common Stock 4375.0 1250 D The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2021. Represents the weighted average sales price per share. The shares were sold at prices ranging from $26.05 to $26.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. All of the shares subject to this option are fully vested and exercisable as of the date hereof. /s/ Michael P. Smith, Attorney-in-fact for Erle T. Mast 2022-01-21